Toll like receptor‐9 agonists stimulate prostate cancer invasion in vitro
- 20 March 2007
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 67 (7), 774-781
- https://doi.org/10.1002/pros.20562
Abstract
BACKGROUND Toll-like receptor 9 (TLR9) recognizes microbial DNA. In addition to immune cells, TLR9 expression has been detected in various cancer cells. We showed recently that TLR9 agonistic CpG-oligonucleotides (CpG-ODNs) induce matrix metalloproteinase-13 (MMP-13)-mediated invasion in TLR9-expressing (TLR9+) breast cancer cells. We investigated here TLR9 expression and function in human prostate cancer (CaP) cells. METHODS TLR9 expression was detected with Western blotting and immunohistochemistry. Invasion was studied with Matrigel-assays. MMP-13 was assayed with ELISA. RESULTS Human CaP cell lines and clinical samples exhibit various levels of TLR9 expression. Treatment of TLR9+, but not TLR9− CaP cells with CpG-ODNs or bacterial DNA increased their invasion, which was inhibited with chloroquine. CpG-ODN-treatment also increased MMP-13 activity and neutralizing anti-MMP-13 antibody prevented CpG-ODN-induced invasion in TLR9+ CaP cells. Estradiol up-regulated TLR9 expression in LnCaP cells. CONCLUSIONS TLR9-mediated invasion may represent a novel mechanism through which infections promote prostate cancer. Prostate 67: 774–781, 2007.Keywords
This publication has 43 references indexed in Scilit:
- Sexual Behavior, Sexually Transmitted Diseases and Prostatitis: The Risk of Prostate Cancer in Black MenJournal of Urology, 2006
- Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNANature Immunology, 2005
- Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosusThe Journal of Experimental Medicine, 2005
- RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll‐like receptor 3Arthritis & Rheumatism, 2005
- TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like ProteinScience, 2005
- CpG Oligonucleotide Therapy Cures Subcutaneous and Orthotopic Tumors and Evokes Protective Immunity in Murine Bladder CancerJournal of Immunotherapy, 2005
- Mechanisms of TLR9 activationInnate Immunity, 2004
- Ligand-regulated Chimeric Receptor Approach Reveals Distinctive Subcellular Localization and Signaling Properties of the Toll-like ReceptorsJournal of Biological Chemistry, 2004
- Toll-Like Receptor Expression in Human Keratinocytes: Nuclear Factor κB Controlled Gene Activation by Staphylococcus aureus is Toll-Like Receptor 2 But Not Toll-Like Receptor 4 or Platelet Activating Factor Receptor DependentJournal of Investigative Dermatology, 2003
- Inflammation and cancerNature, 2002